Charles River Laboratories | CRL - Trade Debtors



Charles River Laboratories reported $767.57M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Agilent USD 1.38B 16M Jul/2025
Align Technology USD 1.12B 54.23M Jun/2025
Bio-Rad Laboratories USD 469.9M 45.2M Jun/2025
Bruker USD 522.6M 15.2M Jun/2025
Cardinal Health USD 13.24B 576M Jun/2025
Charles River Laboratories USD 767.57M 10.94M Jun/2025
Cigna USD 35.44B 8.52B Jun/2025
CVS Health USD 40.65B 1.03B Jun/2025
Danaher USD 4.52B 202M Jun/2025
Dentsply International USD 646M 42M Jun/2025
Elevance Health 23.12B 944M Jun/2025
Galapagos EUR 223.52M 140.03M Jun/2025
Hologic USD 609.3M 35.1M Jun/2025
Humana 4.5B 45M Jun/2025
Illumina USD 701M 2M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
IQVIA Holdings USD 3.41B 95M Jun/2025
Laboratory Of America USD 2.28B 2.2M Jun/2025
Lonza CHF 1.33B 269M Dec/2024
McKesson USD 28.16B 2.52B Jun/2025
Merck EUR 4.92B 62M Jun/2025
Mettler Toledo International USD 681.6M 43.21M Jun/2025
Novartis USD 9.18B 451M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Quest Diagnostics USD 1.42B 15M Jun/2025
Revvity USD 661.14M 43.72M Jun/2025
Thermo Fisher Scientific USD 8.59B 139M Jun/2025
United Therapeutics USD 379.3M 57.3M Jun/2025
UnitedHealth USD 24.14B 28.82B Jun/2025
Waters USD 730.07M 16.8M Jun/2025
West Pharmaceutical Services USD 582.4M 38.8M Jun/2025